172204P.pdf   01/10/2019  Marc Mancini  v.  Boehringer Ingelheim Pharmaceu
   U.S. Court of Appeals Case No:  17-2204
   U.S. District Court for the District of Minnesota - Minneapolis   
   [PUBLISHED] [Loken, Author, with Smith, Chief Judge, and Gruender, Circuit 
   Judge] 
   Civil case - Products liability. In action against the manufacturers of 
   Mirapex, a dopamine agonist used to treat Parkinson's disease, alleging 
   the should be liable for substantial gambling and other financial losses 
   that resulted from obsessive compulsive behavior, a side effect of taking 
   Mirapex, the district court did not err in determining the claims were 
   barred by the applicable two-year California statute of limitations; 
   argument that the statute was tolled because plaintiff was insane when the 
   cause of action accrued rejected on this record; argument that each 
   ingestion of the drug gave rise to a separate and distinct claim under the 
   continuing violations doctrine rejected; the district court did not abuse 
   its discretion in denying plaintiff's motion to stay defendants' motion 
   for summary judgment pending further discovery.